Skip to content

DMT research published in 2023

Page 3 of 3: studies 41 to 56 of 56, newest first. Back to the DMT overview

Studies

Pharmacokinetic and Pharmacodynamic Interaction of the Ayahuasca Constituents Harmine and Dimethyltryptamine (DMT) in the Rat Brain

January 4, 2023 Klemens Egger, Frederik Gudmundsen, Naja Støckel Jessen et al. preprint

RationaleThe psychedelic effects of the traditional Amazonian botanical decoction known as ayahuasca are attributed to the effects of N,N-dimethyltryptamine (DMT) at brain serotonin 5-HT2A receptors. To make oral DMT bioavailable, ayahuasca additionally contains reversible monoamine oxidase A (MAO-A) inhibitors, namely β-carboline alkaloids such as harmine. However, there is lacking biochemical...

DOI: 10.31219/osf.io/cv6ey (opens in new tab) Ayahuasca Harmine Pharmacology Harmaline +5

Endogenous Biosynthesis and Neural Correlates of N,N-dimethyltryptamine

Deep Blue (University of Michigan) 2023 Nicolas G. Glynos

N,N-dimethyltryptamine (DMT) belongs to a class of drugs known as serotonergic psychedelics, which produce profound shifts in consciousness by dramatically altering perception and causing hallucinatory phenomena. In humans, DMT has a rapid onset and the effects, which include feelings of dissociation from external reality, entering into an ‘otherworldly dimension’, and intense internal visual...

DOI: 10.7302/8314 (opens in new tab) Full text (opens in new tab) Endogeny Biosynthesis Biochemistry Enzyme

Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders

Pharmacotherapy in Psychiatry and Neurology 2023 Jakub Schimmelpfennig, Kamila Jankowiak-Siuda

AMA Schimmelpfennig J, Jankowiak-Siuda K. Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):115-130. doi:10.5114/fpn.2023.131979. APA Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023). Therapeutic potential of N,N-dimethyltryptamine in...

Unique biological and physiological properties of endogenous N, N-dimethyltryptamine from the perspective of functioning of the nervous system

Neuropsychiatria i Neuropsychologia 2023 Jakub Schimmelpfennig, Kamila Jankowiak-Siuda 1 citation

AMA Schimmelpfennig J, Jankowiak-Siuda K. Unique biological and physiological properties of endogenous N, N-dimethyltryptamine from the perspective of functioning of the nervous system. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology. 2023;18(1):1-10. doi:10.5114/nan.2023.129068. APA Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023). Unique biological and physiological...

DOI: 10.5114/nan.2023.129068 (opens in new tab) Neuropsychiatry Neuropsychology Perspective graphical Cognition

An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.

Journal of Psychoactive Drugs 2023 Daniel J. Kruger, Nicolas G. Glynos, Christopher W Fields et al. 10 citations

Identifying gaps and strengths in psychedelic-related knowledge is key to developing effective, evidence-based education to inform appropriate use of and harm reduction practices for psychedelics in the naturalistic use landscape. The current study piloted an assessment instrument with questions on legal status, therapeutic potential, and side effects of psychedelics among people reporting...

Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.

International journal of clinical and health psychology : IJCHP 2023 John R. Kelly, Gerard Clarke, Andrew Harkin et al. 33 citations

Moving towards a systems psychiatry paradigm embraces the inherent complex interactions across all levels from micro to macro and necessitates an integrated approach to treatment. Cortical 5-HT2A receptors are key primary targets for the effects of serotonergic psychedelics. However, the therapeutic mechanisms underlying psychedelic therapy are complex and traverse molecular, cellular, and...

Classic psychedelics do not affect T cell and monocyte immune responses.

Frontiers in Psychiatry 2023 Deborah Rudin, Alexander Areesanan, Matthias E. Liechti et al. 9 citations

Classic psychedelics have been shown to exert therapeutic potential for the treatment of various psychiatric disorders, neuropsychiatric diseases, and neuronal damage. Besides their psychopharmacological activity, psychedelics have been reported to modulate immune functions. There has thus far been a sparse exploration of the direct immune-modulating effect of psychedelics on human immune cells...

An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study.

Frontiers in Psychology 2023 Pascal Michael, David Luke, Oliver Robinson 16 citations

N,N-Dimethyltryptamine (DMT) is an endogenous serotonergic psychedelic capable of producing radical shifts in an experience that have significant implications for consciousness and its neural correlates, especially given the "disconnected consciousness" suggested by the "breakthrough" DMT state. Its increasing usage and clinical trial indicate the growing importance of a thorough elucidation of...

Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders.

Frontiers in Pharmacology 2023 Nataliya S. Vorobyeva, Alena A. Kozlova 1 citation correction

• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others. • edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary •...

Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users

Journal of Cognitive Neuroscience 2023 Johannes G. Ramaekers, Pablo Mallaroni, Lilian Kloft et al. 15 citations

Abstract Consumption of the psychedelic brew ayahuasca is a central ritualistic aspect of the Santo Daime religion. The current observational, baseline controlled study was designed to assess whether members (n = 24) of the Santo Daime church would show enhanced capacity for mental imagery during an ayahuasca experience. In addition, this study assessed whether the effects of ayahuasca on...

DOI: 10.1162/jocn_a_02003 (opens in new tab) Ayahuasca DMT Psychedelics Consciousness research +1

This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience.

Frontiers in Psychology 2023 Pascal Michael, David Luke, Oliver Robinson 19 citations

Much research has focused on the modeling of the near-death experience (NDE) by classical and atypical psychedelics; however, to date, no study has reported on the relationship between the NDE and the experience induced by the highly potent, endogenous psychedelic drug 5-Methoxy-DMT (5MeO-DMT). This article presents a case study of an individual who is popularly documented to have had a...

A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Frontiers in Pharmacology 2023 Klemens Egger, Frederik Gudmundsen, Naja Støckel Jessen et al. 17 citations

Rationale: The psychedelic effects of the traditional Amazonian botanical decoction known as ayahuasca are often attributed to agonism at brain serotonin 5-HT2A receptors by N,N-dimethyltryptamine (DMT). To reduce first pass metabolism of oral DMT, ayahuasca preparations additionally contain reversible monoamine oxidase A (MAO-A) inhibitors, namely β-carboline alkaloids such as harmine....

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.

Frontiers in Pharmacology 2023 Dario Dornbierer, Laurenz Marten, Jovin Mueller et al. 32 citations

Recently, the Amazonian plant medicine "ayahuasca"-containing the psychedelic compound N,N-dimethyltryptamine (DMT) and numerous β-carboline alkaloids, such as harmine-has been suggested to exhibit beneficial effects in patients with affective and other mental health disorders. Although ayahuasca ingestion is considered safe, its pharmacokinetics/pharmacodynamics and tolerability profile pose...

DOI: 10.3389/fphar.2023.1246892 (opens in new tab) Full text (opens in new tab) Psychedelics/entheogens/hallucinogens Drug-delivery/formulations/administration Ayahuasca/DMT/Harmine Pharmaceutical-innovation/drug-development

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.

Frontiers in Psychiatry 2023 Helena Aicher, Michael J Mueller, Dario Dornbierer et al. 34 citations

There is growing scientific evidence for the therapeutic benefits of the Amazonian plant-based psychedelic "ayahuasca" for neuropsychiatric disorders such as depression and anxiety. However, there are certain challenges when incorporating botanical ayahuasca into biomedical research and clinical therapy environments. Formulations inspired by ayahuasca, which contain specific and standardized...

DOI: 10.3389/fpsyt.2023.1302559 (opens in new tab) Full text (opens in new tab) DMT Ayahuasca analog Harmine Psychological processes +7

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial.

Frontiers in Psychiatry 2023 Ellen James, David Erritzøe, Tiffanie Benway et al. 16 citations

Due to their potential impact on mood and wellbeing there has been increasing interest in the potential of serotonergic psychedelics such as N,N-dimethyltryptamine (DMT) in the treatment of major depressive disorder (MDD). The aim of Part A of this study was to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) profile of escalating doses of SPL026 (DMT fumarate)...